Elodie Laharanne

IRF4 Gene Rearrangements Define a Subgroup of CD30-Positive Cutaneous T-Cell Lymphoma: A Study of 54 Cases

Anne Pham‐Ledard, Martina Prochazkova‐Carlotti, Elodie Laharanne et al. · Journal of Investigative Dermatology · 2009 · 133 citations · Full text

Lymphoid Neoplasia, Malignant Blood Disorder, Pathology +5

Genome-Wide Analysis of Cutaneous T-Cell Lymphomas Identifies Three Clinically Relevant Classes

Elodie Laharanne, Naïma Oumouhou, Françoise Bonnet et al. · Journal of Investigative Dermatology · 2010 · 112 citations · Full text

Lymphoid Neoplasia, Medicine, Immunology +10

CDKN2A–CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma

Elodie Laharanne, Edith Chevret, Yamina Idrissi et al. · Modern Pathology · 2010 · 92 citations

Lymphoid Neoplasia, Cancer Immunosurveillance, Immunology +6

Autophagy inhibition cooperates with erlotinib to induce glioblastoma cell death

Sandrine Eimer, Marc‐Antoine Belaud‐Rotureau, Kelly Airiau et al. · Cancer Biology & Therapy · 2011 · 67 citations

Mitophagy, Apoptosis, Cell Death +21

Neuroendocrine phenotype as an acquired resistance mechanism in ALK-rearranged lung adenocarcinoma

Charline Caumont, Rémi Veillon, Audrey Gros et al. · Lung Cancer · 2015 · 46 citations

Tumor Biology, Endocrine Oncology, Neuroendocrine Phenotype +10